Urpo Nieminen

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

Clas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen et al. · Scandinavian Journal of Gastroenterology · 2012 · 154 citations

Esophageal Morbidity and Function in Adults With Repaired Esophageal Atresia With Tracheoesophageal Fistula

Saara J. Sistonen, Antti Koivusalo, Urpo Nieminen et al. · Annals of Surgery · 2010 · 150 citations

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Pauliina Molander, Martti Färkkilâ, Ari Ristimäki et al. · Journal of Crohn s and Colitis · 2014 · 94 citations

Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case–control observational study based on registry data

Urpo Nieminen, Airi Jussila, Stig Nordling et al. · International Journal of Cancer · 2013 · 90 citations

Disease Duration, Cumulative Effect, Immunology +20

Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission

Pauliina Molander, Martti Färkkilâ, Kimmo Salminen et al. · Inflammatory Bowel Diseases · 2014 · 75 citations · Full text